 |
市場調查報告書
商品編碼
2079865
生物活性玻璃市場規模、佔有率和成長分析：按類型、形態、應用、最終用戶和地區分類－2026-2033年產業預測Bioactive Glass Market Size, Share, and Growth Analysis, By Type (45S5 Bioglass, Silicate Bioactive Glass), By Form (Granules & Particles, Scaffolds), By Application, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球生物活性玻璃市場價值為 3.825 億美元，預計到 2025 年將成長至 4.1394 億美元，到 2033 年將成長至 7.824 億美元，在預測期（2026-2033 年）內複合年成長率為 8.22%。
全球生物活性玻璃市場的發展動力源自於先進製造技術與醫療應用的創新融合，從而能夠生產出針對每位患者特定骨缺損部位量身定做的支架。外科醫生正利用積層製造技術來微調孔隙率和成分，更精確地使植入形狀與個體解剖結構相匹配，從而縮短手術時間並提高骨整合率。在中國和巴西等國家，政府的支持和已證實的療效正推動這項技術在骨癒合領域的應用日益廣泛。同時，材料供應商也積極尋求研發合作，拓展產品線，並在整形外科、牙科和慢性創傷護理等領域創造新的商機。這反映了一個充滿活力且不斷發展的市場格局。
全球生物活性玻璃市場的成長要素
由於生物活性玻璃已被證實能夠促進組織再生並減輕發炎反應，全球生物活性玻璃市場正經歷顯著成長，這極大地增強了外科醫生和患者的信心。這種信心推動了生物活性玻璃在整形外科、牙科和創傷護理等多種治療方案中的應用。隨著醫療專業人員不斷見證良好的治療效果，他們推薦此類材料的傾向日益增強，製造商也正加大投入，拓展產品線和教育計畫。因此，隨著生物活性玻璃在標準治療中日益普及，市場需求不斷成長，推動了學術界和產業界之間進行更多合作研究，旨在最佳化產品性能並拓展其應用範圍。
全球生物活性玻璃市場的限制因素
由於生物活性玻璃的成本高於傳統材料，全球生物活性玻璃市場面臨嚴峻挑戰。醫療機構，尤其是預算緊張的公共醫療機構，往往不願意將這些先進材料納入常規診療流程。這種成本顧慮導致採購量下降，醫療機構傾向選擇更經濟實惠的替代方案，阻礙了新產品的推廣應用。因此，製造商必須在突出性能優勢和實施價格策略以提高產品可及性之間找到微妙的平衡，力求在全球範圍內獲得注重成本的用戶的廣泛認可。
生物活性玻璃市場的全球趨勢
全球生物活性玻璃市場正經歷著向再生醫學方向發展的重要趨勢，這主要得益於生物活性玻璃技術在組織工程和細胞療法領域的融合。這種協同效應促進了製造商和生物技術公司之間的合作，共同開發包含幹細胞微環境的先進支架，從而加速癒合過程並拓展從骨修復到軟組織再生等更廣泛的臨床應用。這些夥伴關係為創新共同開發契約的達成鋪平了道路，實現了產品差異化並開闢了新的治療機會。因此，生物活性玻璃正成為醫療領域下一代再生醫學解決方案的基石，吸引尋求永續患者照護效果的醫療機構的注意。
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
全球生物活性玻璃市場規模：按類型分類
- 45S5 生物玻璃
- 矽酸鹽基生物活性玻璃
- 磷酸鹽基生物活性玻璃
- 硼酸鹽基生物活性玻璃
全球生物活性玻璃市場規模：依形式分類
- 顆粒/細顆粒
- 鷹架
- 塗層
全球生物活性玻璃市場規模：按應用領域分類
- 骨和牙移植材料
- 創傷護理
- 藥物輸送
全球生物活性玻璃市場規模：依最終用戶分類
- 整形外科診所
- 牙醫診所
- 研究機構
全球生物活性玻璃市場規模：按地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- Mo-Sci Corporation
- Schott AG（BonAlive）
- Vitryxx（Bioactive Glass）
- NovaBone Products
- BioVitrum AB
- Novabone（NovaBone）
- Orthovita（Stryker）
- OsteoScience Foundation
- ApaTech（Baxter）
- Bonalive Biomaterials
- VITOSS（Orthovita/Stryker）
- GRAFTYS
- CAM Bioceramics
- InVivo Therapeutics
- Xpand Biotechnology
- Fluidinova SA
- Ceram-O International
- Biomatlante SAS
- ICx Technologies
- Synergy BioMedical
結論與建議
Global Bioactive Glass Market size was valued at USD 382.5 Million in 2024 and is poised to grow from USD 413.94 Million in 2025 to USD 782.4 Million by 2033, growing at a CAGR of 8.22% during the forecast period (2026-2033).
The global bioactive glass market is driven by the innovative integration of advanced manufacturing techniques and medical applications, enabling the creation of customized scaffolds tailored to patient-specific defects. Surgeons leverage additive manufacturing to fine-tune porosity and composition, ensuring implant geometries align better with individual anatomies, resulting in reduced operating times and enhanced osseointegration. Countries like China and Brazil are increasingly adopting this technology for bone healing due to supportive government incentives and proven efficacy. Concurrently, material suppliers are actively engaging in research and development collaborations, broadening their product offerings and establishing new revenue opportunities across orthopedics, dentistry, and chronic wound care sectors, reflecting a dynamic and evolving market landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioactive Glass market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioactive Glass Market Segments Analysis
Global bioactive glass market is segmented by type, form, application, end-user and region. Based on type, the market is segmented into 45S5 Bioglass, Silicate Bioactive Glass, Phosphate Bioactive Glass and Borate Bioactive Glass. Based on form, the market is segmented into Granules & Particles, Scaffolds and Coatings. Based on application, the market is segmented into Bone & Dental Grafts, Wound Care and Drug Delivery. Based on end-user, the market is segmented into Orthopedic Clinics, Dental Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Bioactive Glass Market
The Global Bioactive Glass market is experiencing significant growth due to its proven ability to enhance tissue regeneration and mitigate inflammatory responses, fostering increased trust among both surgeons and patients. This confidence encourages the adoption of bioactive glass in various treatment protocols across orthopedics, dentistry, and wound care. As healthcare professionals witness consistent positive outcomes, they are more inclined to recommend these materials, prompting manufacturers to diversify their product offerings and invest in educational programs. Consequently, as the integration of bioactive glass into standard therapeutic practices becomes more common, demand escalates, inspiring further collaborative research between academia and industry aimed at optimizing product performance and expanding its applications.
Restraints in the Global Bioactive Glass Market
The Global Bioactive Glass market faces notable challenges due to the high costs associated with bioactive glass compared to conventional materials. Healthcare providers, particularly in sectors where budgets are constrained and public funding is limited, are often hesitant to integrate these advanced materials into standard practices. This financial sensitivity results in lower procurement volumes and stymies the adoption of new products, as facilities tend to favor more affordable alternatives. Consequently, manufacturers must navigate the delicate balance between showcasing performance benefits and implementing pricing strategies that enhance accessibility, aiming to promote wider acceptance among cost-conscious users worldwide.
Market Trends of the Global Bioactive Glass Market
The Global Bioactive Glass market is witnessing a significant trend towards regenerative medicine, driven by the integration of bioactive glass technology and cellular therapies in tissue engineering. This synergy is fostering collaborations between manufacturers and biotech firms to develop advanced scaffolds that incorporate stem-cell niches, resulting in accelerated healing processes and broadened clinical applications, from bone restoration to soft tissue regeneration. These partnerships are paving the way for innovative co-development contracts, enabling product differentiation and unlocking new therapeutic opportunities. As a result, bioactive glass is emerging as a cornerstone for next-generation regenerative solutions in healthcare, appealing to providers aiming for sustainable outcomes in patient care.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Bioactive Glass Market Size by Type & CAGR (2026-2033)
- Market Overview
- 45S5 Bioglass
- Silicate Bioactive Glass
- Phosphate Bioactive Glass
- Borate Bioactive Glass
Global Bioactive Glass Market Size by Form & CAGR (2026-2033)
- Market Overview
- Granules & Particles
- Scaffolds
- Coatings
Global Bioactive Glass Market Size by Application & CAGR (2026-2033)
- Market Overview
- Bone & Dental Grafts
- Wound Care
- Drug Delivery
Global Bioactive Glass Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Orthopedic Clinics
- Dental Clinics
- Research Institutes
Global Bioactive Glass Market Size & CAGR (2026-2033)
- North America (Type, Form, Application, End-User)
- US
- Canada
- Europe (Type, Form, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Form, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Form, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Form, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Mo-Sci Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Schott AG (BonAlive)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vitryxx (Bioactive Glass)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NovaBone Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioVitrum AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novabone (NovaBone)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthovita (Stryker)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OsteoScience Foundation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ApaTech (Baxter)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bonalive Biomaterials
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- VITOSS (Orthovita/Stryker)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GRAFTYS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CAM Bioceramics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- InVivo Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xpand Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidinova SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ceram-O International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomatlante SAS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICx Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synergy BioMedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
